JP2022526099A5 - - Google Patents
Info
- Publication number
- JP2022526099A5 JP2022526099A5 JP2021556257A JP2021556257A JP2022526099A5 JP 2022526099 A5 JP2022526099 A5 JP 2022526099A5 JP 2021556257 A JP2021556257 A JP 2021556257A JP 2021556257 A JP2021556257 A JP 2021556257A JP 2022526099 A5 JP2022526099 A5 JP 2022526099A5
- Authority
- JP
- Japan
- Prior art keywords
- cell population
- tau
- optionally
- repeat domain
- tauri
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024046338A JP7770447B2 (ja) | 2019-03-18 | 2024-03-22 | タウの播種または凝集の遺伝的修飾因子を同定するためのｃｒｉｓｐｒ／ｃａｓスクリーニングプラットフォーム |
| JP2025185469A JP2026012398A (ja) | 2019-03-18 | 2025-11-04 | タウの播種または凝集の遺伝的修飾因子を同定するためのｃｒｉｓｐｒ／ｃａｓスクリーニングプラットフォーム |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962820086P | 2019-03-18 | 2019-03-18 | |
| US62/820,086 | 2019-03-18 | ||
| PCT/US2020/023131 WO2020190932A1 (en) | 2019-03-18 | 2020-03-17 | Crispr/cas screening platform to identify genetic modifiers of tau seeding or aggregation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024046338A Division JP7770447B2 (ja) | 2019-03-18 | 2024-03-22 | タウの播種または凝集の遺伝的修飾因子を同定するためのｃｒｉｓｐｒ／ｃａｓスクリーニングプラットフォーム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022526099A JP2022526099A (ja) | 2022-05-23 |
| JP2022526099A5 true JP2022526099A5 (enExample) | 2023-09-27 |
| JP7461368B2 JP7461368B2 (ja) | 2024-04-03 |
Family
ID=70285889
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021556257A Active JP7461368B2 (ja) | 2019-03-18 | 2020-03-17 | タウの播種または凝集の遺伝的修飾因子を同定するためのｃｒｉｓｐｒ／ｃａｓスクリーニングプラットフォーム |
| JP2024046338A Active JP7770447B2 (ja) | 2019-03-18 | 2024-03-22 | タウの播種または凝集の遺伝的修飾因子を同定するためのｃｒｉｓｐｒ／ｃａｓスクリーニングプラットフォーム |
| JP2025185469A Pending JP2026012398A (ja) | 2019-03-18 | 2025-11-04 | タウの播種または凝集の遺伝的修飾因子を同定するためのｃｒｉｓｐｒ／ｃａｓスクリーニングプラットフォーム |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024046338A Active JP7770447B2 (ja) | 2019-03-18 | 2024-03-22 | タウの播種または凝集の遺伝的修飾因子を同定するためのｃｒｉｓｐｒ／ｃａｓスクリーニングプラットフォーム |
| JP2025185469A Pending JP2026012398A (ja) | 2019-03-18 | 2025-11-04 | タウの播種または凝集の遺伝的修飾因子を同定するためのｃｒｉｓｐｒ／ｃａｓスクリーニングプラットフォーム |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US11845931B2 (enExample) |
| EP (3) | EP4729947A3 (enExample) |
| JP (3) | JP7461368B2 (enExample) |
| KR (3) | KR20260032649A (enExample) |
| CN (2) | CN120648640A (enExample) |
| AU (2) | AU2020241858B2 (enExample) |
| CA (1) | CA3127813A1 (enExample) |
| ES (2) | ES2970541T3 (enExample) |
| IL (2) | IL312893A (enExample) |
| SG (1) | SG11202108091YA (enExample) |
| WO (1) | WO2020190932A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3769090B1 (en) | 2019-03-18 | 2023-11-15 | Regeneron Pharmaceuticals, Inc. | Crispr/cas dropout screening platform to reveal genetic vulnerabilities associated with tau aggregation |
| CN120648640A (zh) | 2019-03-18 | 2025-09-16 | 瑞泽恩制药公司 | 用于鉴定tau接种或聚集的基因修饰因子的CRISPR/Cas筛选平台 |
| CN113906134B (zh) | 2019-06-14 | 2025-06-24 | 瑞泽恩制药公司 | Tau蛋白病模型 |
| WO2023046996A1 (en) * | 2021-09-27 | 2023-03-30 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Method for improved intron tagging and automated clone recognition |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT500379B8 (de) | 2001-02-02 | 2009-08-15 | Axon Neuroscience | Tau-proteine |
| JP2011517838A (ja) | 2008-04-11 | 2011-06-16 | ユーティーシー パワー コーポレイション | マニホルド・サンプを備えたバイポーラプレートおよび燃料電池 |
| US8586526B2 (en) | 2010-05-17 | 2013-11-19 | Sangamo Biosciences, Inc. | DNA-binding proteins and uses thereof |
| US9637739B2 (en) | 2012-03-20 | 2017-05-02 | Vilnius University | RNA-directed DNA cleavage by the Cas9-crRNA complex |
| WO2013141680A1 (en) | 2012-03-20 | 2013-09-26 | Vilnius University | RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX |
| AU2013266968B2 (en) | 2012-05-25 | 2017-06-29 | Emmanuelle CHARPENTIER | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| SG10201708959WA (en) | 2012-07-03 | 2017-11-29 | Univ Washington | Antibodies to tau |
| WO2014033644A2 (en) | 2012-08-28 | 2014-03-06 | Novartis Ag | Methods of nuclease-based genetic engineering |
| AU2013335451C1 (en) | 2012-10-23 | 2024-07-04 | Toolgen Incorporated | Composition for cleaving a target DNA comprising a guide RNA specific for the target DNA and Cas protein-encoding nucleic acid or Cas protein, and use thereof |
| US9910048B2 (en) | 2012-12-03 | 2018-03-06 | Washington University | Method for detection of aggregates in biological samples |
| PL3360964T3 (pl) | 2012-12-06 | 2020-03-31 | Sigma-Aldrich Co. Llc | Modyfikacja i regulacja genomu oparta na crispr |
| EP3031921B1 (en) | 2012-12-12 | 2025-03-12 | The Broad Institute, Inc. | Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications |
| EP2840140B2 (en) | 2012-12-12 | 2023-02-22 | The Broad Institute, Inc. | Crispr-Cas based method for mutation of prokaryotic cells |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| US20140186843A1 (en) | 2012-12-12 | 2014-07-03 | Massachusetts Institute Of Technology | Methods, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof |
| EP2931899A1 (en) | 2012-12-12 | 2015-10-21 | The Broad Institute, Inc. | Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof |
| DK2931891T3 (da) | 2012-12-17 | 2019-08-19 | Harvard College | Rna-styret modificering af menneskelige genomer |
| EP2922393B2 (en) | 2013-02-27 | 2022-12-28 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Gene editing in the oocyte by cas9 nucleases |
| CN112301024A (zh) | 2013-03-15 | 2021-02-02 | 通用医疗公司 | 使用RNA引导的FokI核酸酶(RFN)提高RNA引导的基因组编辑的特异性 |
| EP4286517A3 (en) | 2013-04-04 | 2024-03-13 | President and Fellows of Harvard College | Therapeutic uses of genome editing with crispr/cas systems |
| US9267135B2 (en) | 2013-06-04 | 2016-02-23 | President And Fellows Of Harvard College | RNA-guided transcriptional regulation |
| EP3725885A1 (en) | 2013-06-17 | 2020-10-21 | The Broad Institute, Inc. | Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof |
| WO2015048577A2 (en) | 2013-09-27 | 2015-04-02 | Editas Medicine, Inc. | Crispr-related methods and compositions |
| WO2015065964A1 (en) | 2013-10-28 | 2015-05-07 | The Broad Institute Inc. | Functional genomics using crispr-cas systems, compositions, methods, screens and applications thereof |
| JP2017512751A (ja) | 2014-02-14 | 2017-05-25 | アイピエリアン，インコーポレイティド | タウペプチド、抗タウ抗体、およびそれらの使用方法 |
| US20150376586A1 (en) | 2014-06-25 | 2015-12-31 | Caribou Biosciences, Inc. | RNA Modification to Engineer Cas9 Activity |
| SI3161128T1 (sl) * | 2014-06-26 | 2019-02-28 | Regeneron Pharmaceuticals, Inc. | Postopki in sestavki za ciljano genetsko spremembo in postopki uporabe |
| CA2954791C (en) | 2014-07-14 | 2025-11-18 | The Regents Of The University Of California | CRISPR/CAS TRANSCRIPTIONAL MODULATION |
| WO2016049258A2 (en) | 2014-09-25 | 2016-03-31 | The Broad Institute Inc. | Functional screening with optimized functional crispr-cas systems |
| WO2016106236A1 (en) | 2014-12-23 | 2016-06-30 | The Broad Institute Inc. | Rna-targeting system |
| US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
| US10676735B2 (en) | 2015-07-22 | 2020-06-09 | Duke University | High-throughput screening of regulatory element function with epigenome editing technologies |
| AU2016365720B2 (en) | 2015-12-07 | 2020-11-26 | Arc Bio, Llc | Methods and compositions for the making and using of guide nucleic acids |
| WO2017124100A1 (en) * | 2016-01-14 | 2017-07-20 | Memphis Meats, Inc. | Methods for extending the replicative capacity of somatic cells during an ex vivo cultivation process |
| LT3436077T (lt) | 2016-03-30 | 2025-06-25 | Intellia Therapeutics, Inc. | Lipidų nanodalelių vaisto formos, skirtos crispr/cas komponentams |
| WO2017172764A1 (en) | 2016-04-01 | 2017-10-05 | The Regents Of The University Of California | Modified cell line and method of determining tauopathies |
| CN110267985B (zh) | 2017-01-04 | 2023-05-23 | H.隆德贝克有限公司 | 用于治疗眼科疾病的特异性针对过度磷酸化τ蛋白的抗体 |
| GB201708998D0 (en) | 2017-06-06 | 2017-07-19 | Univ Leuven Kath | Methods for identifying activators and suppressors |
| WO2019010384A1 (en) | 2017-07-07 | 2019-01-10 | The Broad Institute, Inc. | METHODS FOR DESIGNING GUIDE SEQUENCES FOR GUIDED NUCLEASES |
| CN110891420B (zh) | 2017-07-31 | 2022-06-03 | 瑞泽恩制药公司 | Cas转基因小鼠胚胎干细胞和小鼠及其应用 |
| EP3592140A1 (en) | 2018-03-19 | 2020-01-15 | Regeneron Pharmaceuticals, Inc. | Transcription modulation in animals using crispr/cas systems |
| CA3133983A1 (en) | 2019-03-18 | 2020-09-24 | Regeneron Pharmaceuticals, Inc. | Methods and systems for crispr selection |
| CN120648640A (zh) | 2019-03-18 | 2025-09-16 | 瑞泽恩制药公司 | 用于鉴定tau接种或聚集的基因修饰因子的CRISPR/Cas筛选平台 |
| EP3769090B1 (en) | 2019-03-18 | 2023-11-15 | Regeneron Pharmaceuticals, Inc. | Crispr/cas dropout screening platform to reveal genetic vulnerabilities associated with tau aggregation |
| CN113906134B (zh) | 2019-06-14 | 2025-06-24 | 瑞泽恩制药公司 | Tau蛋白病模型 |
-
2020
- 2020-03-17 CN CN202510881160.XA patent/CN120648640A/zh active Pending
- 2020-03-17 US US16/821,453 patent/US11845931B2/en active Active
- 2020-03-17 KR KR1020267005903A patent/KR20260032649A/ko active Pending
- 2020-03-17 KR KR1020217030636A patent/KR102695765B1/ko active Active
- 2020-03-17 SG SG11202108091YA patent/SG11202108091YA/en unknown
- 2020-03-17 EP EP25223891.0A patent/EP4729947A3/en active Pending
- 2020-03-17 ES ES20718950T patent/ES2970541T3/es active Active
- 2020-03-17 ES ES23215659T patent/ES3064222T3/es active Active
- 2020-03-17 AU AU2020241858A patent/AU2020241858B2/en active Active
- 2020-03-17 CA CA3127813A patent/CA3127813A1/en active Pending
- 2020-03-17 EP EP23215659.6A patent/EP4317950B1/en active Active
- 2020-03-17 CN CN202080021710.6A patent/CN113631700B/zh active Active
- 2020-03-17 IL IL312893A patent/IL312893A/en unknown
- 2020-03-17 IL IL286357A patent/IL286357B2/en unknown
- 2020-03-17 EP EP20718950.7A patent/EP3768826B1/en active Active
- 2020-03-17 JP JP2021556257A patent/JP7461368B2/ja active Active
- 2020-03-17 WO PCT/US2020/023131 patent/WO2020190932A1/en not_active Ceased
- 2020-03-17 KR KR1020247027001A patent/KR102933093B1/ko active Active
-
2023
- 2023-11-06 US US18/502,499 patent/US12209238B2/en active Active
-
2024
- 2024-03-22 JP JP2024046338A patent/JP7770447B2/ja active Active
- 2024-08-23 AU AU2024216321A patent/AU2024216321B2/en active Active
- 2024-12-17 US US18/984,162 patent/US12421512B2/en active Active
-
2025
- 2025-08-20 US US19/305,157 patent/US20260049305A1/en active Pending
- 2025-11-04 JP JP2025185469A patent/JP2026012398A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022526099A5 (enExample) | ||
| JP2024071489A5 (enExample) | ||
| CN107922944B (zh) | 工程改造的crispr-cas9组合物和使用方法 | |
| ES3009026T3 (en) | High-throughput screening of regulatory element function with epigenome editing technologies | |
| JP2022526297A5 (enExample) | ||
| JP6012633B2 (ja) | 特異的プロモーターの構築のための方法 | |
| US20180340176A1 (en) | Crispr-cas sgrna library | |
| CN111511906A (zh) | 核酸引导性核酸酶 | |
| WO2018145068A1 (en) | An integrated system for programmable dna methylation | |
| Lemp et al. | Cryptic transcripts from a ubiquitous plasmid origin of replication confound tests for cis-regulatory function | |
| JP2023508731A5 (enExample) | ||
| WO2022199511A1 (zh) | 一种Lt1Cas13d蛋白及基因编辑系统 | |
| WO2019191876A1 (en) | Method for Screening and Identifying Functional lncRNAs | |
| WO2023174305A1 (zh) | Rna靶向基因编辑工具的开发 | |
| JP7835414B2 (ja) | プライム編集システムを用いたゲノム編集のプロセスで起こり得るオフターゲットを予測するための方法 | |
| RU2024112968A (ru) | Скрининговая платформа crispr/cas для идентификации генетических модификаторов засева или агрегации тау-белка | |
| CN117487777A (zh) | 一种VI-J型CRISPR-Cas13基因编辑系统及其应用 | |
| CN116875581A (zh) | 利用Cpf1非滞留端提高基因敲进效率和精准度的方法 | |
| RU2021127294A (ru) | Скрининговая платформа crispr/cas для идентификации генетических модификаторов засева или агрегации тау-белка | |
| CN103898137B (zh) | 一种含有malat1基因3’utr序列和双荧光素酶报告基因的质粒及其应用 | |
| WO2019127116A1 (zh) | 细胞表型研究用的细胞克隆及其筛选方法和应用 | |
| Ramakrishnan et al. | A high-content flow cytometry and dual CRISPR-Cas9 based platform to quantify genetic interactions | |
| WO2020036181A1 (ja) | 細胞を単離又は同定する方法及び細胞集団 | |
| US20260125662A1 (en) | Method for improving efficiency and accuracy of gene knock-in using non-residence end of cpf1 | |
| RU2021129022A (ru) | Платформа crispr/cas для исключающего скрининга для выявления генетических уязвимостей, связанных с агрегацией тау-белка |